Immune Response News and Research

RSS
Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Duke receives federal funding for HIV vaccine research

Duke receives federal funding for HIV vaccine research

Oxford researchers report findings from Phase 1 clinical trial of intranasal COVID-19 vaccine

Oxford researchers report findings from Phase 1 clinical trial of intranasal COVID-19 vaccine

Study provides new insights into the origin and development of B cells

Study provides new insights into the origin and development of B cells

Scientists discover a promising strategy for development of broad-spectrum antiviral therapies

Scientists discover a promising strategy for development of broad-spectrum antiviral therapies

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

UMSOM researchers identify how multiple genes of SARS-CoV-2 affect disease severity

UMSOM researchers identify how multiple genes of SARS-CoV-2 affect disease severity

Study uncovers how the TAZ protein protects hematopoietic stem cells from aging

Study uncovers how the TAZ protein protects hematopoietic stem cells from aging

MSU researchers use big data and AI to identify existing drugs to fight new COVID-19 variants

MSU researchers use big data and AI to identify existing drugs to fight new COVID-19 variants

Scientists investigate the antibody titers post-mRNA COVID-19 booster vaccine in the elderly

Scientists investigate the antibody titers post-mRNA COVID-19 booster vaccine in the elderly

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

Stanford researchers create new technique for controlling protein production

Stanford researchers create new technique for controlling protein production

Epigenetics drug used to treat blood cancers, rare sarcomas can halt bladder cancer growth

Epigenetics drug used to treat blood cancers, rare sarcomas can halt bladder cancer growth

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Study reveals the determinants of persistent and severe COVID-19

Study reveals the determinants of persistent and severe COVID-19

Study provides insight into cellular and molecular mechanisms involved in COVID-19 delirium

Study provides insight into cellular and molecular mechanisms involved in COVID-19 delirium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.